We are live on ! Find out more
PMD

Psychemedics Corporation

Delisted

PMD was delisted on the 12th of December, 2024.

52 hedge funds and large institutions have $44.5M invested in Psychemedics Corporation in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4% less funds holding

Funds holding: 5452 (-2)

10% less capital invested

Capital invested by funds: $49.4M → $44.5M (-$4.86M)

32% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 22

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
52
Holders Change
-2
Holders Change %
-3.7%
% of All Funds
1.13%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
1
Increased
15
Reduced
22
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
IFAM
51
Institutional & Family Asset Management
Colorado
$1K
LSV Asset Management
52
LSV Asset Management
Illinois
-$531K -33,508 Closed
NFG
53
Next Financial Group
Texas
-$8K -500 Closed
Fifth Third Bancorp
54
Fifth Third Bancorp
Ohio
-$5K -300 Closed

PMD Hedge Fund Activity: Q1 2019 in Review

52 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q1 2019, worth a combined $44.5M — down 9.8% from $49.4M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PMD and 1 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 15 added.

The largest buyer was Kennedy Capital Management, adding an estimated $1.36M. The largest seller was LSV Asset Management, exiting entirely with an estimated $531K sold.

  • 52 institutional investors held Psychemedics Corporation (PMD) as of Q1 2019, down from 54 in Q4 2018.
  • Funds reported $44.5M of Psychemedics Corporation stock for Q1 2019, down 9.8% quarter-over-quarter.
  • 1 fund opened new Psychemedics Corporation positions in Q1 2019 and 3 closed out, a net change of -2 holders.
  • The largest Psychemedics Corporation buyer in Q1 2019 was Kennedy Capital Management, an estimated $1.36M added.
  • The largest Psychemedics Corporation seller in Q1 2019 was LSV Asset Management, an estimated $531K sold.

Based on aggregated 13F filings for Q1 2019.